EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
25 hedge funds and large institutions have $11.3M invested in Evelo Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-14
Holders Change %
-35.9%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
8
Reduced
13
Closed
15
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$27K
Top Buyers
| 1 |
1
Barclays
London,
United Kingdom
|
$303K |
| 2 |
2
Morgan Stanley
New York
|
$18.5K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$10.8K |
| 4 |
4
Group One Trading
Chicago,
Illinois
|
$3.31K |
| 5 |
5
Citigroup
New York
|
$309 |
